| Synthetic peptides in the form of dendrimers become resistant to protease activity L Bracci, C Falciani, B Lelli, L Lozzi, Y Runci, A Pini, MG De Montis, ... Journal of Biological Chemistry 278 (47), 46590-46595, 2003 | 215 | 2003 |
| Making sense of rodent models of anhedonia S Scheggi, MG De Montis, C Gambarana International Journal of Neuropsychopharmacology 21 (11), 1049-1065, 2018 | 197 | 2018 |
| Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum O Giorgi, G De Montis, ML Porceddu, S Mele, G Calderini, G Toffano, ... Developmental Brain Research 35 (2), 283-290, 1987 | 193 | 1987 |
| A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study C Gambarana, F Masi, A Tagliamonte, S Scheggi, O Ghiglieri, ... Journal of neurochemistry 72 (5), 2039-2046, 1999 | 173 | 1999 |
| Long‐term behavioral and neurochemical effects of chronic stress exposure in rats S Mangiavacchi, F Masi, S Scheggi, B Leggio, MG De Montis, ... Journal of neurochemistry 79 (6), 1113-1121, 2001 | 165 | 2001 |
| The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway MC Olianas, GM De Montis, G Mulas, A Tagliamonte European journal of pharmacology 49 (3), 233-241, 1978 | 164 | 1978 |
| Hypothalamus–pituitary–adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats A Raone, A Cassanelli, S Scheggi, R Rauggi, B Danielli, MG De Montis Neuroscience 146 (4), 1734-1742, 2007 | 135 | 2007 |
| Animal models for the study of antidepressant activity C Gambarana, S Scheggi, A Tagliamonte, P Tolu, MG De Montis Brain Research Protocols 7 (1), 11-20, 2001 | 130 | 2001 |
| G protein-linked receptors: pharmacological evidence for the formation of heterodimers R Maggio, P Barbier, A Colelli, F Salvadori, G Demontis, GU Corsini Journal of Pharmacology and Experimental Therapeutics 291 (1), 251-257, 1999 | 127 | 1999 |
| Profile of spinal and supra-spinal antinociception of (−)-linalool AT Peana, MG De Montis, E Nieddu, MT Spano, SD Paolo, P Pippia European journal of pharmacology 485 (1-3), 165-174, 2004 | 125 | 2004 |
| Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats D Meloni, C Gambarana, MG De Montis, P Dal Prá, I Taddei, ... Pharmacology Biochemistry and Behavior 46 (2), 423-426, 1993 | 121 | 1993 |
| Selective increase of brain dopamine synthesis by sulpiride GGL Tagliamonte A, De Montis MG, Olianas MC, Vargiu L J. Neurochem 24, 707-710, 1975 | 120 | 1975 |
| Involvement of adenosine A1 and A2A receptors in (−)-linalool-induced antinociception AT Peana, P Rubattu, GG Piga, S Fumagalli, G Boatto, P Pippia, ... Life sciences 78 (21), 2471-2474, 2006 | 118 | 2006 |
| "Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants GLG Serra G., M. Collu, P.S. D'Aquila, M.G. De Montis Brain Res 527, 234-243, 1990 | 105 | 1990 |
| gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor. KG Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, ... Journal of Pharmacology and Experimental Therapeutics 220 (3), 672-677, 1982 | 105 | 1982 |
| PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors M Melis, S Scheggi, G Carta, C Madeddu, S Lecca, A Luchicchi, ... Journal of Neuroscience 33 (14), 6203-6211, 2013 | 103 | 2013 |
| Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones MC Olianas, GM De Montis, A Concu, A Tagliamonte, G Di Chiara European Journal of Pharmacology 49 (3), 223-232, 1978 | 96 | 1978 |
| Effects of (−)-linalool in the acute hyperalgesia induced by carrageenan, L-glutamate and prostaglandin E2 AT Peana, MG De Montis, S Sechi, G Sircana, SD Paolo, P Pippia European journal of pharmacology 497 (3), 279-284, 2004 | 94 | 2004 |
| 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors ML Porceddu, O Giorgi, G De Montis, S Mele, L Cocco, E Ongini, G Biggio Life sciences 41 (6), 697-706, 1987 | 84 | 1987 |
| Efficacy of an Hypericum perforatum (St. John's wort) extract in preventing and reverting a condition of escape deficit in rats C Gambarana, O Ghiglieri, P Tolu, MG De Montis, D Giachetti, ... Neuropsychopharmacology 21 (2), 247-257, 1999 | 80 | 1999 |
